Home/Filings/4/0001628280-23-007310
4//SEC Filing

MILLER MARK C 4

Accession 0001628280-23-007310

CIK 0000727207other

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 4:24 PM ET

Size

12.0 KB

Accession

0001628280-23-007310

Insider Transaction Report

Form 4
Period: 2023-03-07
Transactions
  • Exercise/Conversion

    Common Stock

    2023-03-07+4,39655,282 total
  • Exercise/Conversion

    Employee Restricted Stock Units

    2023-03-0750,8860 total
    Common Stock (50,886 underlying)
  • Exercise/Conversion

    Employee Restricted Stock Units

    2023-03-074,3960 total
    Common Stock (4,396 underlying)
  • Exercise/Conversion

    Common Stock

    2023-03-07+50,88650,886 total
Holdings
  • Common Stock

    (indirect: By Trust)
    39,062
Footnotes (2)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the "Vesting Date"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served. This reporting person received a prorated amount of 50,886 RSUs, which is eight of the twelve months.
  • [F2]The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 4,396 RSUs. All of the RSUs vested on the first-year anniversary of the Date of Grant. These RSUs are subject to the Company's Director Equity Deferral Program and were released within 30 days of separation from service.

Issuer

Accelerate Diagnostics, Inc

CIK 0000727207

Entity typeother

Related Parties

1
  • filerCIK 0001021410

Filing Metadata

Form type
4
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 4:24 PM ET
Size
12.0 KB